ORIC | ORIC Pharmaceuticals (NASDAQ:ORIC) Upgraded to Sell by BidaskClub

ORIC Pharmaceuticals (NASDAQ:ORIC) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports.ORIC has been the topic of several other research reports.Robert W.Baird began coverage on ORIC Pharmaceuticals in a report on Wednesday, August 12th.They set an “outperform” rating and […]Dispatch Tribunal